1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:
10.3322/caac.21262
.
2. Rakha EA, Ellis IO. Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics. Adv Anat Pathol. 2011;18:255–67. doi:
10.1097/PAP.0b013e318220f5d1
.
3. Allred C, Miller K, Viale G, Brogi E, Isola J. Molecular testing for estrogen receptor, progesterone receptor, and HER2. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organisation classification of tumours of the breast. Lyon: IARC; 2012. p. 22–3.
4. Schnitt SJ, Allred C, Britton P, Ellis IO, Lakhani SR, Morrow M, et al. Ductal carcinoma in situ. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organisation classification of tumours of the breast. Lyon: IARC; 2012. p. 90–4.
5. Ellis IO, Collins L, Ichihara S, MacGrogan G. Invasive carcinoma of no special type. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organisation classification of tumours of the breast. Lyon: IARC; 2012. p. 33–4.